Cargando…
Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases
INTRODUCTION: Advanced atherosclerotic lesions are characterized by lipid accumulation, inflammation, and defective efferocytosis. An ideal therapy should address all aspects of this multifactorial disease. Ixmyelocel-T therapy, an expanded autologous multicellular therapy showing clinical promise i...
Autores principales: | Ledford, Kelly J, Murphy, Nikki, Zeigler, Frank, Bartel, Ronnda L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029553/ https://www.ncbi.nlm.nih.gov/pubmed/24405662 http://dx.doi.org/10.1186/scrt346 |
Ejemplares similares
-
Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases
por: Ledford, Kelly J, et al.
Publicado: (2015) -
Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages
por: Ledford, Kelly J, et al.
Publicado: (2013) -
From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T
por: Bartel, Ronnda L., et al.
Publicado: (2013) -
The Aastrom experience
por: Bartel, Ronnda L, et al.
Publicado: (2012) -
Epigenetic modulation in the treatment of atherosclerotic disease
por: Byrne, Mikaela M., et al.
Publicado: (2014)